Delivery Order 75F40119D10041-75F40120F19003

Award Date 9/16/20
Potential Completion Date 9/29/21
Potential Value $2.3M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Mountain View, CA 94040, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $954,448.72 delivery order contract to Dnanexus, Inc., doing business as Dnanexus Inc., located in Mountain View, California. The contract period is from February 18, 2022 through February 21, 2023 and utilizes a firm fixed price contract type. Under the terms of the contract, Dnanexus Inc. will provide services to accept Real World Data through PrecisionFDA into the Food and Drug Administration's Intelligent...
The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...
The Department of Health and Human Services Food and Drug Administration awarded a $607,840 delivery order to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will provide its cloud-based platform as a service under a firm fixed price contract to support FDA's regulatory science programs. The place of performance will be in Silver Spring, Maryland. The one year contract starts in August 2021 and runs through August 2022 to give FDA researchers access...
The Department of Health and Human Services Food and Drug Administration awarded a $2.8 million firm fixed price delivery order contract to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will deliver its cloud-based precisionFDA platform to support the FDA's regulatory science programs over a one year period of performance ending in September 2022. No subcontractors or set aside designations were identified. This contract leverages Dnanexus' existing...
Dnanexus, Inc. was awarded a $227,106.90 firm fixed price delivery order against the PrecisionFDA Public Instance of GSRS O&M contract by the Department of Health and Human Services' Food and Drug Administration. This delivery order provides operations and maintenance support for the PrecisionFDA public instance through May 30, 2024. No set-aside designation was used for this award. Work will be performed in Silver Spring, Maryland and supports the FDA's ongoing management and enhancement of...
This $1,134,088.88 firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. to provide a Common Data Harmonization System FIDLE Integration. The contract has a period of performance through March 31, 2024 and is not set aside. Dnanexus, a for-profit organization, has a history of supporting FDA initiatives like the PrecisionFDA program, providing cloud-based bioinformatics tools and genomic analysis platform services to the regulatory...
This is a firm fixed-price delivery order contract awarded to Dnanexus, Inc. by the Food and Drug Administration (FDA) to provide operations and maintenance support for the agency's PrecisionFDA platform. The $4,073,921.12 contract has a period of performance through September 29, 2024 and does not have a set-aside designation. Dnanexus is a for-profit company that specializes in cloud-based genomics data management and analysis services. Through prior federal contracts, Dnanexus has supported...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
This federal contract award is for the PrecisionFDA platform, a FISMA-authorized secure cloud-based data repository and analysis platform for FDA researchers, reviewers, bioinformaticians, and data scientists. The $3,132,275.15 firm fixed price delivery order was awarded to Dnanexus, Inc., a for-profit company based in Mountain View, California that specializes in cloud-based genomics data management and analysis services. This contract supports critical initiatives in precision medicine,...
This federal contract award to DnaNexus, Inc., doing business as DnaNexus Inc., is a $240,904.24 firm-fixed-price delivery order for the operation and maintenance of the U.S. Food and Drug Administration's (FDA) PrecisionFDA public instance of the Global Submission Registry System (GSRS). The contract has a period of performance through May 31, 2025 and was awarded on June 3, 2024. This award is not associated with a set-aside program. DnaNexus is a for-profit organization that has previously...
  • 75F40119D10041
    Indefinite Delivery Contract
  • 75F40119D10041-75F40120F19003
    Delivery Order

The Department of Health and Human Services Food and Drug Administration awarded a $2.3 million delivery order contract to Dnanexus, Inc. for Increment B of PrecisionFDA. Dnanexus will provide labor hours to further develop PrecisionFDA, an FDA initiative that applies bioinformatics and computational biology to regulatory science. The one-year contract was awarded on September 16, 2020 and has a period of performance through September 29, 2021. Work will be conducted by Dnanexus at its Mountain View, California location to advance this important HHS program focused on applying emerging technologies to regulatory review processes.

Generated 12/25/23, 5:46 AM